Board Member
Canopy Growth Corp (CGC)Equibles does not estimate personal net worth.
Get an email with a short summary when Canopy Growth Corp publishes a filing, an earnings call transcript or a press release.
Get CGC alertsLuc Mongeau is recorded as Board Member at Canopy Growth Corp (CGC) since January 1, 2024 and CEO at Canopy Growth Corp (CGC). The newest filing on record that lists Luc Mongeau as CEO and Board Member at Canopy Growth Corp (CGC) is dated August 7, 2026. Canopy Growth Corp reported in an 8-K filed November 26, 2024 that Luc Mongeau was appointed Chief Executive Officer, effective January 6, 2025. Luc Mongeau has spoken on 7 earnings calls across 1 company, most recently for Canopy Growth Corp on August 7, 2026. Canopy Growth Corp is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Canopy Growth Corp includes Judy A (Chairman), Judy Hong (CFO and Chief Accounting Officer), Thomas Stewart (CFO and Chief Accounting Officer) and 7 others.
“On November 26, 2024, the board of directors (the “Board”) of Canopy Growth Corporation (the “Company”) appointed Luc Mongeau, a current member of the Board, to serve as Chief Executive Officer (“CEO”) of the Company (the “Appointment”), effective January 6, 2025 (the “Start Date”).”
“Good morning, everyone. and thank you for joining us today fiscal 2027 is after a strong start and it's built on real momentum from fiscal 2026. i'm confident to say that our first quarter results have us well positioned to build on that momentum all year long fiscal 2026 was all about sharpening our focus tightening…”
“PISCO 2026 was a defining year for canopy growth. We made the hard calls early, streamlining the business, sharpening our focus, and relocating resources to where we see the greatest long-term opportunity.”
“Q3 was a quarter where Canopy Growth delivered significant progress on multiple levels, and it reinforced my confidence that we're building stronger business. For me, the fundamentals of the business are both about how the business is performing and our financial strength which allows us to execute with discipline.”
“It's great to be with you again to share the continued progress we're making in building a competitive, profitable and trusted leader in the global cannabis market.”
“It's great to be with you again to share the momentum building across our business and how it's translating into top-line growth. To begin, I'm very encouraged by the performance that our cannabis business delivered in the first quarter.”
2024-01-01–present
Last confirmed August 7, 2026
Start not stated–present
Last confirmed August 7, 2026
Drug Manufacturers - Specialty & Generic · Healthcare
CEO, Board Member
2024-01-01–present
